Literature DB >> 16630063

Intravenous self-administration of nicotine is altered by lesions of the posterior, but not anterior, pedunculopontine tegmental nucleus.

Helen L Alderson1, Mary P Latimer, Philip Winn.   

Abstract

The reinforcing properties of nicotine involve actions at nicotinic acetylcholine receptors located on dopamine (DA) neurons in the ventral tegmental area (VTA). The pedunculopontine tegmental nucleus (PPTg) is involved in the regulation of these DA neurons, and those of the substantia nigra pars compacta (SNc). The PPTg can be subdivided into anterior (aPPTg) and posterior (pPPTg) regions on the basis of its innervation of midbrain DA neurons - the pPPTg innervates both VTA and SNc while the aPPTg innervates SNc. As the reinforcing actions of nicotine depend on its actions in the VTA more than SNc, it was hypothesized that excitotoxic lesions of pPPTg would alter nicotine reinforcement, measured by intravenous self-administration, while lesions of aPPTg would not. Rats were given ibotenate lesions of pPPTg or aPPTg, followed by intravenous catheterization. Intravenous self-administration (IVSA) of nicotine (0.03 mg/kg/inf) was carried out until a stable response baseline was reached. A dose-response function for nicotine was then established. There was no significant effect of aPPTg lesions on nicotine IVSA, while IVSA was significantly elevated following pPPTg lesions, compared with both sham lesioned controls and aPPTg excitotoxin lesioned rats. This was found across all doses, including saline, of the dose-response function. The differential effect of aPPTg lesions and pPPTg lesions suggests that disruption of regulatory innervation from pPPTg results in altered regulation of VTA DA neurons. The resulting change in nicotine self-administration behaviour was hypothesized to reflect either a reduction in intrinsic nicotine reward value, or enhancement of associative incentive salience.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16630063     DOI: 10.1111/j.1460-9568.2006.04737.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  25 in total

1.  Nicotine self-administration in the rat: effects of hypocretin antagonists and changes in hypocretin mRNA.

Authors:  Mark G LeSage; Jennifer L Perry; Catherine M Kotz; David Shelley; William A Corrigall
Journal:  Psychopharmacology (Berl)       Date:  2010-02-24       Impact factor: 4.530

2.  Stimulation of nicotine reward and central cholinergic activity in Sprague-Dawley rats exposed perinatally to a fat-rich diet.

Authors:  Irene Morganstern; Olga Lukatskaya; Sang-Ho Moon; Wei-Ran Guo; Jane Shaji; Olga Karatayev; Sarah F Leibowitz
Journal:  Psychopharmacology (Berl)       Date:  2013-07-09       Impact factor: 4.530

3.  Intra-ventral tegmental area microinjections of urotensin II modulate the effects of cocaine.

Authors:  L E Mueller; M A Kausch; T Markovic; D A A MacLaren; D M Dietz; J Park; S D Clark
Journal:  Behav Brain Res       Date:  2014-10-01       Impact factor: 3.332

Review 4.  Systems level neuroplasticity in drug addiction.

Authors:  Matthew W Feltenstein; Ronald E See
Journal:  Cold Spring Harb Perspect Med       Date:  2013-05-01       Impact factor: 6.915

Review 5.  Structural and functional considerations of the cholinergic brainstem.

Authors:  Juan Mena-Segovia
Journal:  J Neural Transm (Vienna)       Date:  2016-03-05       Impact factor: 3.575

6.  Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence.

Authors:  Riju Ray; Nandita Mitra; Don Baldwin; Mengye Guo; Freda Patterson; Daniel F Heitjan; Christopher Jepson; E Paul Wileyto; Jinxue Wei; Thomas Payne; Jennie Z Ma; Ming D Li; Caryn Lerman
Journal:  Neuropsychopharmacology       Date:  2010-02-10       Impact factor: 7.853

Review 7.  Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system.

Authors:  Fernando Berrendero; Patricia Robledo; José Manuel Trigo; Elena Martín-García; Rafael Maldonado
Journal:  Neurosci Biobehav Rev       Date:  2010-02-16       Impact factor: 8.989

Review 8.  Cholinergic modulation of mesolimbic dopamine function and reward.

Authors:  Gregory P Mark; Shkelzen Shabani; Lauren K Dobbs; Stephen T Hansen
Journal:  Physiol Behav       Date:  2011-05-01

9.  Midbrain dopamine neurons: projection target determines action potential duration and dopamine D(2) receptor inhibition.

Authors:  Elyssa B Margolis; Jennifer M Mitchell; Junko Ishikawa; Gregory O Hjelmstad; Howard L Fields
Journal:  J Neurosci       Date:  2008-09-03       Impact factor: 6.167

Review 10.  The cholinergic mesopontine tegmentum is a relatively neglected nicotinic master modulator of the dopaminergic system: relevance to drugs of abuse and pathology.

Authors:  U Maskos
Journal:  Br J Pharmacol       Date:  2008-01-28       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.